{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:09:48Z","timestamp":1790359788927,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.gene.2014.03.049","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:52:21Z","timestamp":1395881541000},"page":"109-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR\/ABL positive CML patients"],"prefix":"10.1016","volume":"542","author":[{"given":"Dolly","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chandrakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Korgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu Rao","family":"Vundinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2014.03.049_bb0005","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","article-title":"Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth","volume":"6","author":"Agirre","year":"2008","journal-title":"Molecular Cancer Research"},{"key":"10.1016\/j.gene.2014.03.049_bb0010","first-page":"263","article-title":"MIRN 199B downregulation in chronic myeloid leukaemia is associated with deletions on der (9)","volume":"144","author":"Albano","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"35","key":"10.1016\/j.gene.2014.03.049_bb0015","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.gene.2014.03.049_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of the c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelotic leukemia","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.03.049_bb0025","first-page":"1661","article-title":"Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)","volume":"4","author":"Beran","year":"1998","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.gene.2014.03.049_bb0030","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"26","author":"Calin","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2014.03.049_bb0035","article-title":"MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia","volume":"154","author":"Chaubey","year":"2008","journal-title":"Leukemia Advance"},{"key":"10.1016\/j.gene.2014.03.049_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.gene.2014.03.049_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-4608(01)00412-5","article-title":"Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis","volume":"128","author":"Cohen","year":"2001","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1016\/j.gene.2014.03.049_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1016\/j.gene.2014.03.049_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in imatinib-resistant chronic myeloid leukemia patients without clinically significant ABLI-mutations","volume":"8","author":"Eneriz","year":"2009","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.gene.2014.03.049_bb0060","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3324\/haematol.2009.020636","article-title":"Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia","volume":"95","author":"Flamant","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.gene.2014.03.049_bb0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2006.10.006","article-title":"MicroRNA expression and function in cancer","volume":"12","author":"Garzon","year":"2006","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.gene.2014.03.049_bb0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.gene.2014.03.049_bb0075","doi-asserted-by":"crossref","first-page":"D154","DOI":"10.1093\/nar\/gkm952","article-title":"miRBase: tools for microRNA genomics","volume":"36","author":"Griffiths","year":"2008","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.gene.2014.03.049_bb0085","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntley","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.gene.2014.03.049_bb0080","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1182\/blood.V99.12.4547","article-title":"Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability","volume":"99","author":"Huntley","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gene.2014.03.049_bb0090","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood-2003-01-0123","article-title":"Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia","volume":"102","author":"Huntley","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.gene.2014.03.049_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/gcc.10056","article-title":"Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia","volume":"34","author":"Loncarevic","year":"2002","journal-title":"Genes, Chromosomes & Cancer"},{"key":"10.1016\/j.gene.2014.03.049_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0014-4827(60)90138-5","article-title":"Hungerford: chromosome preparations of leucocytes cultures from human peripheral blood","volume":"20","author":"Moorhead","year":"1960","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.gene.2014.03.049_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/cyto.990100105","article-title":"Three color fluorescence in-situ hybridization for the simultaneous detection of multiple nucleic acid sequences","volume":"10","author":"Nederlof","year":"1989","journal-title":"Cytometry"},{"issue":"9","key":"10.1016\/j.gene.2014.03.049_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative Expression Software Tool (REST\u00a9) for group-wise comparison and statistical analysis of relative expression results in real time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.gene.2014.03.049_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giesma staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.03.049_bb0120","series-title":"ISCN 2009: An International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2009"},{"key":"10.1016\/j.gene.2014.03.049_bb0125","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia","volume":"95","author":"Sinclair","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.gene.2014.03.049_bb0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0609.2011.01689.x","article-title":"Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review","volume":"87","author":"Vaidya","year":"2011","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.gene.2014.03.049_bb0135","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells","volume":"109","author":"Venturini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.gene.2014.03.049_bb0140","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1158\/0008-5472.CAN-10-1684","article-title":"Dysregulation of the mitogen granulin in human cancer through the miR-15\/107 microRNA gene group","volume":"70","author":"Wang","year":"2010","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/j.gene.2014.03.049_bb0145","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2003-04-1150","article-title":"Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib","volume":"102","author":"Wilkinson","year":"2003","journal-title":"Blood"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T18:06:57Z","timestamp":1597601217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111914003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0378111914003849"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2014.03.049","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR\/ABL positive CML patients","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2014.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}